Related Experiment Video
Updated: May 6, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Nucleolar dysfunction in Huntington's disease
Junghee Lee1, Yu Jin Hwang2, Hyun Ryu3
1VA Boston Healthcare System, Boston, MA 02130, USA; Boston University, Alzheimer's Disease Center, Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA.
Insights
Huntington's disease involves genetic mutations affecting neuronal function. This review explores how epigenetic modifications in the nucleolus, specifically involving upstream binding factor (UBF), may offer new therapeutic targets for this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Epigenetics
Background:
- Huntington's disease (HD) is a fatal neurodegenerative disorder caused by CAG repeat expansion in the huntingtin gene.
- The precise mechanisms leading to selective medium spiny neuron loss in HD remain unclear.
- Emerging evidence links nucleolar stress and dysfunction to HD pathogenesis, including deregulation of ribosomal DNA (rDNA) transcription.
Purpose of the Study:
- To review the role of nucleolar stress and epigenetic modifications in Huntington's disease.
- To discuss the impact of post-translational modifications on upstream binding factor (UBF) and rDNA transcription in HD.
Main Methods:
- Literature review focusing on nucleolar function, epigenetic regulation, and Huntington's disease.
- Analysis of the interplay between histone acetyltransferase, histone methyltransferase, and UBF in rDNA transcription.
- Examination of the link between nucleolar alterations and neuronal damage in HD.
Main Results:
- Mutant huntingtin may induce nucleolar stress, affecting rDNA transcription.
- Epigenetic modifications, particularly those involving UBF, are implicated in the nucleolar dysfunction observed in HD.
- Histone acetyltransferase and histone methyltransferase activities influence UBF post-translational modifications and rDNA transcription.
Conclusions:
- Understanding the epigenetic modulation of UBF-dependent rDNA transcription in the nucleolus is crucial for HD research.
- This knowledge may lead to the identification of novel pathological markers for HD.
- Targeting nucleolar epigenetic pathways presents a potential therapeutic strategy for Huntington's disease.
Abstract:
Huntington's disease (HD) is a fatal genetic disorder characterized by triad clinical symptoms of chorea, emotional distress, and cognitive decline. Genetic mutation in HD is identified by an expansion of CAG repeats coding for glutamine (Q) in exon 1 of the huntingtin (htt) gene. The exact mechanism on how mutant htt leads to the selective loss of medium spiny neurons (MSNs) in the striatum is still unknown. Recent studies suggest that nucleolar stress and dysfunction are linked to the pathogenesis of HD. Alterations of the nucleolar activity and integrity contribute to deregulation of ribosomal DNA (rDNA) transcription in HD pathogenesis. Furthermore, epigenetic modifications in the nucleolus are associated with neuronal damage in HD. In this review, we discuss about how post-translational modifications of upstream binding factor (UBF) are affected by histone acetyltransferase and histone methyltransferase and involved in the transcriptional regulation of rDNA in HD. The understanding of epigenetic modulation of UBF-dependent rDNA transcription in the nucleolus may lead to the identification of novel pathological markers and new therapeutic targets to treat HD. This article is part of a Special Issue entitled: Role of the Nucleolus in Human Disease.
More Related Videos
Related Concept Videos
Huntington Disease l: Introduction
The Nucleolus
Lysosomal Hydrolases
Parkinson Disease ll: Pathophysiology
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Neural Regulation

